Francis Duhay

CIK: 0001760582

Transaction Breakdown

Open Market Buys (P)1 (12.5%)

High conviction signal

Open Market Sales (S)5 (62.5%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NVNO

enVVeno Medical Corp

Director

Discretionary Trading P&L

Holdings

Transaction History (8 total)

NVNO
enVVeno Medical Corp
Sep 11, 2026
Sale(S)
Direct
11 shares at avg. $11.21$123.31
NVNO
enVVeno Medical Corp
Jun 11, 2026
Sale(S)
Direct
140 shares at avg. $10.30$1K
NVNO
enVVeno Medical Corp
Mar 12, 2026
Sale(S)
Direct
140 shares at avg. $11.52$2K
NVNO
enVVeno Medical Corp
Dec 11, 2025
Award(A)
Stock Options
Direct
135.9K shares-
NVNO
enVVeno Medical Corp
Dec 11, 2025
Sale(S)
Direct
4.9K shares at avg. $0.36$2K
NVNO
enVVeno Medical Corp
Sep 15, 2025
Sale(S)
Direct
4.9K shares at avg. $0.83$4K
NVNO
enVVeno Medical Corp
Dec 31, 2024
Purchase(P)
Direct
81.4K shares at avg. $3.07$250K
NVNO
enVVeno Medical Corp
Dec 18, 2024
Award(A)
Stock Options
Direct
19.8K shares-

		Type	Shares	Price		Ownership
Sep 11, 2026	NVNO enVVeno Medical Corp	Sale(S)	11	$11.21	$123	Direct
Jun 11, 2026	NVNO enVVeno Medical Corp	Sale(S)	140	$10.30	$1,443	Direct
Mar 12, 2026	NVNO enVVeno Medical Corp	Sale(S)	140	$11.52	$1,613	Direct
Dec 11, 2025	NVNO enVVeno Medical Corp	Award(A) Stock Options	135,883	-	-	Direct
Dec 11, 2025	NVNO enVVeno Medical Corp	Sale(S)	4,900	$0.36	$1,742	Direct
Sep 15, 2025	NVNO enVVeno Medical Corp	Sale(S)	4,900	$0.83	$4,067	Direct
Dec 31, 2024	NVNO enVVeno Medical Corp	Purchase(P)	81,433	$3.07	$249,999	Direct
Dec 18, 2024	NVNO enVVeno Medical Corp	Award(A) Stock Options	19,752	-	-	Direct

1-8 of 8 transactions

About Duhay Francis

Duhay Francis (SEC CIK 0001760582) files insider reports with the SEC as Director of enVVeno Medical Corp (NVNO).

Signal8 holds 8 ownership filings by Duhay Francis, all Form 4s, filed between Dec 20, 2024 and Sep 14, 2026. Those filings report 8 transactions, from Dec 18, 2024 to Sep 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Duhay Francis's filings is in IRVINE, CA.

Recent filings by Duhay Francis

Sep 11, 2026: Open-market sale of NVNO shares (Form 4, code S).
Jun 11, 2026: Open-market sale of NVNO shares (Form 4, code S).
Mar 12, 2026: Open-market sale of NVNO shares (Form 4, code S).
Dec 11, 2025: Grant or award of NVNO derivative securities (Form 4, code A).
Dec 11, 2025: Open-market sale of NVNO shares (Form 4, code S).

Other insiders filing for enVVeno Medical Corp (NVNO)

BERMAN ROBERT ANDREW, Chief Executive Officer
Alavi Hamed, Chief Technology Officer
Glickman Marc H., SVP & Chief Medical Officer
Gray Robert, Director
Jenusaitis Matthew, Director
Shrivastava Sanjay, Director

How to read Form 4 transaction codes